Document:

EXHIBIT
10.1

 

WRITTEN
CONSENT OF DIRECTORS TO CORPORATE ACTION

WITHOUT
MEETING OF PHI GROUP, INC.

TO
EXTEND REPURCHASE OF COMMON STOCK 

 

The
undersigned, being all of the directors of the Board of Directors of PHI Group, Inc., a corporation originally incorporated in
the State of Nevada on June 08, 1982 and redomiciled in the State of Wyoming on September 20, 2017 (the “Company”),
and thus constituting a quorum, hereby adopt the following resolutions in lieu of a meeting on this 29th day of June
2020.

 

WHEREAS,
on March 04, 2020 the Company’s Board of Directors passed
a corporate resolution to extend the time period for the repurchase of its own shares of common stock from the open market from
time to time in accordance with the terms mentioned below:

 

	1.	Purpose
    of Repurchase: To enhance future shareholder returns.
	2.	Details
    of Repurchase: 

	 	a.
    	Class
    of shares to be repurchased: Common Stock of PHI Group, Inc.
	 	b.	Total
    number of repurchasable shares: Up to 13 billion shares, or more as may be needed.
	 	c.	Total
    repurchase amount: To be determined by prevalent market prices at times of transaction.
	 	d.	Methods
    of repurchase: Open market purchase and/or negotiated transactions.
	 	e.	Repurchase
    period: Until and including June 30, 2020.
	 	f.	The
    Company intends to fund the proposed share repurchase program with the proceeds from the disposal of a portion of certain
    non-core assets and from future earnings of the Company.
	 	g.	The
    share repurchase program will be in full compliance with state and federal laws and certain covenants with the Company’s
    note-holders.

 

WHEREAS,
in light of the adverse effects due to the prevalent coronavirus pandemic as well as the Company’s current corporate priorities,
its Board of Directors has determined that it is in the best interests of the Company and its shareholders to extend the Common
Stock repurchase period to December 31, 2020.

 

BE
IT RESOLVED, that the Corporation is authorized to repurchase its own shares of common stock from the open market from time
to time in accordance with the terms mentioned below:

 

	1.	Purpose
    of Repurchase: To enhance future shareholder returns.
	2.	Details
    of Repurchase: 

	 	a.
    	Class
    of shares to be repurchased: Common Stock of PHI Group, Inc.
	 	b.	Total
    number of repurchasable shares: Up to 13 billion shares, or more as may be needed.
	 	c.	Total
    repurchase amount: To be determined by prevalent market prices at times of 
	 	 	transaction.
	 	d.	Methods
    of repurchase: Open market purchase and/or negotiated transactions.
	 	e.	Repurchase
    period: As soon as possible until December 31, 2020.
	 	f.	The
    Company intends to fund the proposed share repurchase program with the proceeds from the disposal of a portion of certain
    non-core assets and from anticipated revenues of the Company.
	 	g.	The
    share repurchase program will be in full compliance with state and federal laws and certain covenants with the Company’s
    note-holders.

 

FURTHER
RESOLVED that in addition to and without limiting the foregoing, each officer of the Company be and hereby is authorized and
directed to take, or cause to be taken, such further action, and to execute and deliver, or cause to be delivered, for and in
the name and on behalf of the Company, all such instruments and documents as such officer may deem necessary, appropriate or in
the best interests of the Company to effectuate the intent of the foregoing resolutions and the transactions contemplated thereby
(as conclusively evidenced by the taking of such actions or the execution and delivery of such instruments and documents, as the
case may be) and all action heretofore taken by such officer in connection with the subject of the foregoing recitals and resolutions
be, and it hereby is, approved, ratified and confirmed in all respects as the act and deed of the Company.

 

By
their signatures below, the above resolutions have been duly authorized and adopted by the Company’s Board of Directors.

 

	Dated:
    June 29, 2020	 	 
	 	 	 
	/s/
Tam Bui 	 	/s/
    Frank Hawkins
	Tam
Bui, Director 	 	Frank
    Hawkins, Director
	 	 	 
	/s/
    Henry Fahman	 	 
	Henry
Fahman, DirectorEXHIBIT
10.2

 

WRITTEN
CONSENT OF DIRECTORS TO CORPORATE ACTION

WITHOUT
MEETING OF PHI GROUP, INC.

TO
EXTEND RECORD DATE FOR SPECIAL STOCK DIVIDEND DISTRIBUTION

 

The
undersigned, being all of the directors of the Board of Directors of PHI Group, Inc., a corporation originally incorporated in
the State of Nevada on June 08, 1982 and redomiciled in the State of Wyoming on September 20, 2017 (the “Company”),
hereby adopt the following resolutions in lieu of a meeting on this 29th day of June 2020.

 

WHEREAS,
on December 30, 2019 the Company’s Board of Directors amended the new dividend ratio and the new Record Date for a special
stock dividend from its holdings of Common Stock in American Pacific Resources, Inc., a subsidiary of the Company, to shareholders
of Common Stock of the Company as follows: (a) Eligible shareholders: In order to be eligible for the above-mentioned special
stock dividend, the minimum amount of Common Stock of PHI Group, Inc. each shareholder must hold as of the June 30, 2020 (the
New Record Date) is twenty (20) shares; (b) Dividend ratio: All eligible shareholders of Common Stock of the Company as of the
new Record Date will be entitled to receive one (1) share of Common Stock of American Pacific Resources, Inc. for every twenty
(20) shares of Common Stock of PHI Group, Inc. held by such shareholders as of the new Record date; and (c) Payment Date: the
Payment Date for the distribution of the special stock dividend to be ten (10) business days after a registration statement for
said special stock dividend shares is declared effective by the Securities and Exchange Commission.

 

WHEREAS,
due to the adverse effects of the prevalent coronavirus pandemic, it deems necessary for the Company to further extend the
Record Date of the American Pacific Resources, Inc. (“APR”) special stock dividend to December 31, 2020 in order to
enable the Company to comply with the contractual obligations in connection with certain outstanding convertible notes and at
the same time to allow APR additional time to reach certain milestones that would make the planned spin-off of this subsidiary
economically significant to the Company’s shareholders;

 

NOW,
THEREFORE, BE IT RESOLVED, that the Company further extend the Record Date to December 31, 2020 and reiterate the provisions
for the afore-mentioned stock dividend as follows: (a) Eligible shareholders: In order to be eligible for the above-mentioned
special stock dividend, the minimum amount of Common Stock of PHI Group, Inc. each shareholder must hold as of December 31, 2020
(the New Record Date) is twenty (20) shares; (b) Dividend ratio: All eligible shareholders of Common Stock of the Company as of
the new Record Date will be entitled to receive one (1) share of Common Stock of American Pacific Resources, Inc. for every twenty
(20) shares of Common Stock of PHI Group, Inc. held by such shareholders as of the new Record date; and (c) Payment Date: the
Payment Date for the distribution of the special stock dividend to be ten (10) business days after a registration statement for
said special stock dividend shares is declared effective by the Securities and Exchange Commission.

 

FURTHER
RESOLVED that in addition to and without limiting the foregoing, each officer of the Company be and hereby is authorized and
directed to take, or cause to be taken, such further action, and to execute and deliver, or cause to be delivered, for and in
the name and on behalf of the Company, all such instruments and documents as such officer may deem necessary, appropriate or in
the best interests of the Company to effectuate the intent of the foregoing resolutions and the transactions contemplated thereby
(as conclusively evidenced by the taking of such actions or the execution and delivery of such instruments and documents, as the
case may be) and all action heretofore taken by such officer in connection with the subject of the foregoing recitals and resolutions
be, and it hereby is, approved, ratified and confirmed in all respects as the act and deed of the Company.

 

By
their signatures below, the above resolutions have been duly authorized and adopted by the Company’s Board of Directors.

 

	Dated:
    June 29, 2020	 	 
	 	 	 
	/s/
    Tam Bui	 	/s/
    Henry D. Fahman
	Tam
    Bui, Director 	 	Henry
    D. Fahman, Director
	 	 	 
	/s/
    Frank Hawkins 	 	 
	Frank
    Hawkins, DirectorExhibit 4.1

 

PLACEMENT AGENCY AGREEMENT

June 26, 2020

 

Globus Maritime Limited

128 Vouliagmenis Avenue, 3rd Floor

166 74 Glyfada

Athens, Greece

Attention: Athanasios Feidakis, Chief Executive Officer

 

Dear Mr. Feidakis:

 

This agreement (the “Agreement”)
constitutes the agreement between Maxim Group LLC (the “Placement Agent”) and Globus
Maritime Limited, a Republic of the Marshall Islands corporation (the “Company”), pursuant to which the
Placement Agent shall serve as the exclusive placement agent for the Company, on a “reasonable best efforts” basis,
in connection with the proposed placement (the “Placement”) of registered common shares (the “Shares”)
of the Company, par value $0.004 per share (the “Common Stock”) and unregistered Warrants (collectively,
the “Warrants”) to purchase shares of Common Stock (the shares of Common Stock underlying the Warrants, collectively
with the Warrants and the Shares, the “Securities”).  The terms of the Placement and the Securities shall
be mutually agreed upon by the Company and the purchasers (each, a “Purchaser” and collectively, the “Purchasers”)
and nothing herein constitutes that the Placement Agent would have the power or authority to bind the Company or any Purchaser
or an obligation for the Company to issue any Securities or complete the Placement.  This Agreement and the documents executed
and delivered by the Company and the Purchasers in connection with the Placement, including but not limited to the Purchase Agreement
(as defined below) and the form of the Warrants shall be collectively referred to herein as the “Transaction Documents.” 
The date of the closing of the Placement shall be referred to herein as the “Closing Date.”  The Company
expressly acknowledges and agrees that the Placement Agent’s obligations hereunder are on a reasonable best efforts basis
only and that the execution of this Agreement does not constitute a commitment by the Placement Agent to purchase the Securities
and does not ensure the successful placement of the Securities or any portion thereof or the success of the Placement Agent with
respect to securing any other financing on behalf of the Company.  With the prior written consent of the Company, the Placement
Agent may retain other brokers or dealers to act as sub-agents or selected-dealers on its behalf in connection with the Placement. 
The sale of the Securities to any Purchaser will be evidenced by a securities purchase agreement (the “Purchase Agreement”)
between the Company and such Purchaser in a form reasonably acceptable to the Company and the Placement Agent.  Capitalized
terms that are not otherwise defined herein have the meanings given to such terms in the Purchase Agreement.  Prior to the
signing of any Purchase Agreement, officers of the Company will be available to answer inquiries from prospective Purchasers.

 

    

     

    

 

SECTION 1.     
REPRESENTATIONS AND WARRANTIES OF THE COMPANY; COVENANTS OF THE COMPANY.

 

A.               
Representations of the Company.  Each of the representations and warranties (together with any related
disclosure schedules thereto) and covenants made by the Company to the Purchasers in the Purchase Agreement in connection with
the Placement is hereby incorporated herein by reference into this Agreement (as though fully restated herein) and is, as of the
date of this Agreement and as of the Closing Date, hereby made to, and in favor of, the Placement Agent. In addition to the foregoing,
the Company represents and warrants that:

 

1.                  The
Company has prepared and filed with the U.S. Securities and Exchange Commission (the “Commission”) a
registration statement on Form F-3 (Registration No. 333-222580), and amendments thereto, and related preliminary
prospectuses, for the registration under the Securities Act of 1933, as amended (the “Securities Act”), of
the Shares, which registration statement, as so amended (including post-effective amendments, if any) became effective on
February 8, 2018.  At the time of such filing, the Company met the requirements of Form F-3 under the Securities Act.
Such registration statement meets the requirements set forth in Rule 415(a)(1)(x) under the Securities Act and complies with
said Rule. The Company will file with the Commission pursuant to Rule 424(b) under the Securities Act, and the rules and
regulations (the “Rules and Regulations”) of the Commission promulgated thereunder, a supplement to the
form of prospectus included in such registration statement relating to the placement of the Shares and the plan of
distribution thereof and has advised the Placement Agent of all further information (financial and other) with respect to the
Company required to be set forth therein. Such registration statement, including the exhibits thereto, as amended at the date
of this Agreement, is hereinafter called the “Registration Statement”; such prospectus in the form in
which it appears in the Registration Statement is hereinafter called the “Base Prospectus”; and the
supplemented form of prospectus, in the form in which it will be filed with the Commission pursuant to Rule 424(b) (including
the Base Prospectus as so supplemented) is hereinafter called the “Prospectus Supplement.” Any reference
in this Agreement to the Registration Statement, the Base Prospectus or the Prospectus Supplement shall be deemed to refer to
and include the documents incorporated by reference therein (the “Incorporated Documents”) pursuant to
Item 6 of Form F-3 which were filed under the Exchange Act on or before the date of this Agreement, or the issue date of the
Base Prospectus or the Prospectus Supplement, as the case may be; and any reference in this Agreement to the terms
 “amend,” “amendment” or “supplement” with respect to the Registration Statement, the Base
Prospectus or the Prospectus Supplement shall be deemed to refer to and include the filing of any document under the Exchange
Act after the date of this Agreement, or the issue date of the Base Prospectus or the Prospectus Supplement, as the case may
be, deemed to be incorporated therein by reference. All references in this Agreement to financial statements and schedules
and other information which is “contained,” “included,” “described,”
 “referenced,” “set forth” or “stated” in the Registration Statement, the Base Prospectus
or the Prospectus Supplement (and all other references of like import) shall be deemed to mean and include all such financial
statements and schedules and other information which is or is deemed to be incorporated by reference in the Registration
Statement, the Base Prospectus or the Prospectus Supplement, as the case may be. No stop order suspending the effectiveness
of the Registration Statement or the use of the Base Prospectus or the Prospectus Supplement has been issued, and no
proceeding for any such purpose is pending or has been initiated or, to the Company’s knowledge, is threatened by the
Commission. For purposes of this Agreement, “free writing prospectus” has the meaning set forth in Rule
405 under the Securities Act and the “Time of Sale Prospectus” means the preliminary prospectus, if any,
together with the free writing prospectuses, if any, used in connection with the Placement, including any documents
incorporated by reference therein.

 

    2

     

    

 

2.                 
The Registration Statement (and any further documents to be filed with the Commission) contains all exhibits and
schedules as required by the Securities Act. Each of the Registration Statement and any post-effective amendment thereto, at the
time it became effective, complied in all material respects with the Securities Act and the Exchange Act and the applicable Rules
and Regulations and did not and, as amended or supplemented, if applicable, will not, contain any untrue statement of a material
fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading.
The Base Prospectus, the Time of Sale Prospectus and the Prospectus Supplement, each as of its respective date, comply in all material
respects with the Securities Act and the Exchange Act and the applicable Rules and Regulations. Each of the Base Prospectus, the
Time of Sale Prospectus and the Prospectus Supplement, as amended or supplemented, did not and will not contain as of the date
thereof any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein,
in the light of the circumstances under which they were made, not misleading. The Incorporated Documents, when they were filed
with the Commission, conformed in all material respects to the requirements of the Exchange Act and the applicable Rules and Regulations,
and none of such documents, when they were filed with the Commission, contained any untrue statement of a material fact or omitted
to state a material fact necessary to make the statements therein (with respect to Incorporated Documents incorporated by reference
in the Base Prospectus or Prospectus Supplement), in the light of the circumstances under which they were made not misleading;
and any further documents so filed and incorporated by reference in the Base Prospectus, the Time of Sale Prospectus or Prospectus
Supplement, when such documents are filed with the Commission, will conform in all material respects to the requirements of the
Exchange Act and the applicable Rules and Regulations, as applicable, and will not contain any untrue statement of a material fact
or omit to state a material fact necessary to make the statements therein, in the light of the circumstances under which they were
made, not misleading. No post-effective amendment to the Registration Statement reflecting any facts or events arising after the
date thereof which represent, individually or in the aggregate, a fundamental change in the information set forth therein is required
to be filed with the Commission. There are no documents required to be filed with the Commission in connection with the transaction
contemplated hereby that (x) have not been filed as required pursuant to the Securities Act or (y) will not be filed within the
requisite time period. There are no contracts or other documents required to be described in the Base Prospectus, the Time of Sale
Prospectus or Prospectus Supplement, or to be filed as exhibits or schedules to the Registration Statement, which (x) have not
been described or filed as required or (y) will not be filed within the requisite time period.

 

3.                  The
Company is eligible to use free writing prospectuses in connection with the Placement pursuant to Rules 164 and 433 under the
Securities Act. Any free writing prospectus that the Company is required to file pursuant to Rule 433(d) under the Securities
Act has been, or will be, filed with the Commission in accordance with the requirements of the Securities Act and the
applicable rules and regulations of the Commission thereunder. Each free writing prospectus that the Company has filed, or is
required to file, pursuant to Rule 433(d) under the Securities Act or that was prepared by or behalf of or used by the
Company complies or will comply in all material respects with the requirements of the Securities Act and the applicable rules
and regulations of the Commission thereunder. The Company will not, without the prior consent of the Placement Agent,
prepare, use or refer to, any free writing prospectus.

 

    3

     

    

 

4.                 
There are no affiliations with any FINRA member firm among the Company’s officers, directors or, to the knowledge
of the Company, any five percent (5.0%) or greater shareholder of the Company, except as set forth in the Registration Statement
and the other documents the Company has filed or furnished with the Commission.

 

B.                
Covenants of the Company. The Company has delivered, or will as promptly as practicable deliver, to the
Placement Agent materially complete conformed copies of the Registration Statement and of each consent and certificate of experts,
as applicable, filed as a part thereof, and conformed copies of the Registration Statement (without exhibits), the Base Prospectus,
the Time of Sale Prospectus and the Prospectus Supplement, as amended or supplemented, in such quantities and at such places as
the Placement Agent reasonably requests. Neither the Company nor any of its directors and officers has distributed and none of
them will distribute, prior to the Closing Date, any offering material in connection with the offering and sale of the Securities
pursuant to the Placement other than the Base Prospectus, the Time of Sale Prospectus, the Prospectus Supplement, the Registration
Statement, copies of the documents incorporated by reference therein and any other materials permitted by the Securities Act.

 

SECTION
2.      REPRESENTATIONS
OF THE PLACEMENT AGENT. The Placement Agent  represents and warrants that it (i) is a member in good standing of FINRA,
(ii) is registered as a broker/dealer under the Exchange Act, (iii) is licensed as a broker/dealer under the laws of the states
applicable to the offers and sales of the Securities by such Placement Agent, (iv) is and will be a body corporate validly existing
under the laws of its place of incorporation, and (v) has full power and authority to enter into and perform its obligations under
this Agreement.  The Placement Agent will immediately notify the Company in writing of any change in its status as such.
The Placement Agent covenants that it will use its reasonable best efforts to conduct the Placement hereunder in compliance with
the provisions of this Agreement and the requirements of applicable law.  In accordance with Section 4(i) of that certain
Underwriting Agreement dated June 18, 2020 by and between the Placement Agent and the Company, the Placement Agent consents to
the entry by the Company into the Transaction Documents and the consummation of the transactions contemplated thereunder.

 

SECTION
3.      COMPENSATION.  In
consideration of the services to be provided for hereunder, the Company shall pay to the Placement Agent or their respective designees
their pro rata portion (based on the Securities placed) of the following compensation with respect to the Securities which
they are placing:

 

A.               
A cash fee (the “Cash Fee”) equal to an aggregate of seven percent (7%) of the aggregate
gross proceeds raised in the Placement.  The Cash Fee shall be paid at the closing of the Placement (the “Closing”).

 

    4

     

    

 

B.                
 Subject to compliance with FINRA Rule 5110(f)(2)(D), the Company also agrees, in case of Closing of the Placement,
to reimburse the Placement Agent for all travel and other out-of-pocket expenses incurred, including the reasonable fees, costs
and disbursements of its legal counsel, in an amount not to exceed an aggregate of $45,000 (against invoices provided to the Company). 
The Company will reimburse Placement Agent directly upon the Closing of the Placement from the gross proceeds raised in the Placement
(if detailed invoices are provided in advance).

 

C.                
In addition, if within the Participation Period (as defined below) the Company completes any financing of equity,
equity-linked, or debt (but excluding commercial or bank debt) of the Company (other than the exercise by any person or entity
of any options, warrants or other convertible securities) with any of the investors, each of whom was introduced to the Company
or contacted by the Placement Agent on the Company’s behalf prior to the Closing, which are identified to the Company in
writing by the Placement Agent at or prior to Closing, except for any such investors with whom the Company had a pre-existing business
relationship prior to the public offering consummated by the Company pursuant to that certain Underwriting Agreement dated June
18, 2020 by and between the Placement Agent and the Company (the “PA Investors”), if the Placement Agent is
not acting as an underwriter or placement agent in such financing, then the Company will pay to the Placement Agent upon the closing
of such financing as a financing participation right the compensation set forth in Section 3(A) above with respect the funds received
by the Company from the PA Investors. The “Participation Period” shall be the period of time nine (9) months after
the Closing.

 

D.               
The Placement Agent reserves the right to reduce any item of its compensation or adjust the terms thereof as specified
herein in the event that a determination shall be made by FINRA to the effect that such Placement Agent’s aggregate compensation
is in excess of FINRA rules or that the terms thereof require adjustment.

 

SECTION
4.      INDEMNIFICATION.
The Company agrees to the indemnification and other agreements set forth in the Indemnification Provisions (the “Indemnification”)
attached hereto as Addendum A, the provisions of which are incorporated herein by reference and shall survive the
termination or expiration of this Agreement.

 

SECTION
5.      ENGAGEMENT TERM.
The Placement Agent’s engagement hereunder shall be until the earlier of (i) the final closing date of the Placement, (ii)
the date the Company elects to terminate this Agreement, and (iii) July 15, 2020 (the period of time during which this Agreement
remains in effect is referred to herein as the “Term”).  If the Company elects to terminate this Agreement
prior to Closing for any reason even though the Placement Agent and all purchasers under the Purchase Agreement were prepared
to proceed with the Closing within the intent of this Agreement and the Purchase Agreement, and if within nine (9) months following
such termination, the Company completes any financing of equity, equity-linked or debt (but excluding commercial or bank debt)
of the Company (other than the exercise by any person or entity of any options, warrants or other convertible securities) with
any PA Investor, if the Placement Agent is not acting as an underwriter or placement agent in such financing, then the Company
will pay the Placement Agent upon the closing of such financing the compensation set forth in Section 3(A) above to the extent
of the gross proceeds received by the Company from such PA Investors. Notwithstanding anything to the contrary contained herein,
the provisions concerning confidentiality and indemnification and contribution contained herein and the Company’s obligations
contained in the Indemnification Provisions will survive any expiration or termination of this Agreement. The Placement Agent
agrees not to use any confidential information concerning the Company provided to the Placement Agent by the Company for any purposes
other than those contemplated under this Agreement.

 

    5

     

    

 

SECTION
6.      PLACEMENT AGENT
INFORMATION. The Company agrees that any information or advice rendered by the Placement Agent in connection with this engagement
is for the confidential use of the Company only in their evaluation of the Placement and, except as otherwise required by law,
the Company will not disclose or otherwise refer to the advice or information in any manner without the Placement Agent’s
prior written consent.

 

SECTION
7.      NO FIDUCIARY RELATIONSHIP.
This Agreement does not create, and shall not be construed as creating rights enforceable by any person or entity not a party
hereto, except those entitled hereto by virtue of the Indemnification Provisions hereof. The Company acknowledges and agrees that
the Placement Agent is not and shall not be construed as a fiduciary of the Company and shall have no duties or liabilities to
the equity holders or the creditors of the Company or any other person by virtue of this Agreement or the retention of such Placement
Agent hereunder, all of which are hereby expressly waived.

 

SECTION
8.      CLOSING. The
obligations of the Placement Agent, and the closing of the sale of the Securities hereunder are subject to the accuracy, when
made and on the Closing Date, of the representations and warranties on the part of the Company and its subsidiaries contained
herein and in the Purchase Agreement, to the accuracy of the statements of the Company and its subsidiaries made in any certificates
pursuant to the provisions hereof, to the performance by the Company and its subsidiaries of their obligations hereunder, and
to each of the following additional terms and conditions, except as otherwise disclosed to and acknowledged and waived by the
Placement Agent to the Company:

 

A.               
No stop order suspending the effectiveness of the Registration Statement shall have been issued and no proceedings
for that purpose shall have been initiated or threatened by the Commission, and any request for additional information on the part
of the Commission (to be included in the Registration Statement, the Base Prospectus, the Prospectus Supplement or otherwise) shall
have been complied with to the reasonable satisfaction of the Placement Agent. Any filings required to be made by the Company in
connection with the Placement shall have been timely filed with the Commission.

 

B.                
The Placement Agent shall not have discovered and disclosed to the Company on or prior to the Closing Date that the
Registration Statement, the Base Prospectus, the Prospectus Supplement or any amendment or supplement thereto contains an untrue
statement of a fact which, in the reasonable opinion of counsel for the Placement Agent, is material or omits to state any fact
which, in the reasonable opinion of such counsel, is material and is required to be stated therein or is necessary to make the
statements therein not misleading.

 

C.                 All
corporate proceedings and other legal matters incident to the authorization, form, execution, delivery and validity of each
of this Agreement, the Shares, the Registration Statement, the Base Prospectus and the Prospectus Supplement and all other
legal matters relating to this Agreement and the transactions contemplated hereby shall be reasonably satisfactory in all
material respects to counsel for the Placement Agent, and the Company shall have furnished to such counsel all documents and
information that they may reasonably request to enable them to pass upon such matters.

 

    6

     

    

 

D.               
The Placement Agent shall have received from outside counsel to the Company such counsel’s written opinions,
addressed to the Placement Agent and the Purchasers and dated as of the Closing Date, in form and substance reasonably satisfactory
to the Placement Agent.

 

E.                
On the Closing Date, the Placement Agent shall have received a “comfort” letter from Ernst
 & Young (Hellas) Certified Auditors-Accountants S.A. (the Company’s independent registered accounting firm) (“E&Y”) as
of each such date, addressed to each of the Placement Agent and in form and substance satisfactory in all respects to the Placement
Agent and Placement Agent’s counsel.

 

F.                 
On the Closing Date, Placement Agent shall have received a certificate of the chief financial officer of the Company,
dated, as applicable, as of the date of such Closing, to the effect that, as of the date of this Agreement and as of the applicable
date, the representations and warranties of the Company contained herein and in the Purchase Agreement were and are accurate in
all material respects, except for such changes as are contemplated by this Agreement and except as to representations and warranties
that were expressly limited to a state of facts existing at a time prior to the applicable Closing Date, and that, as of the applicable
date, the obligations to be performed by the Company hereunder on or prior thereto have been fully performed in all material respects. 
Such officer shall also provide a customary certification as to such accounting or financial matters that are included or incorporated
by reference in the Registration Statement or the Prospectus Supplement that E&Y is unable to provide assurances on in
the letter contemplated by Section 8(E) above.

 

G.               
On the Closing Date, Placement Agent shall have received a certificate of the Secretary of the Company, dated, as
applicable, as of the date of such Closing, certifying to the organizational documents, good standing in the jurisdiction of incorporation
of the Company and board resolutions relating to the Placement of the Securities from the Company.

 

H.                Neither
the Company nor any of its subsidiaries (i) shall have sustained since the date of the latest audited financial statements
included or incorporated by reference in the Registration Statement, the Base Prospectus and the Prospectus Supplement, any
loss or interference with its business from fire, explosion, flood, terrorist act or other calamity, whether or not covered
by insurance, or from any labor dispute or court or governmental action, order or decree, otherwise than as set forth in or
contemplated by the Registration Statement, the Base Prospectus and the Prospectus Supplement, (ii) since such date there
shall not have been any change in the capital stock or long-term debt of the Company or any of its subsidiaries or any
change, or any development involving a prospective change, in or affecting the business, general affairs, management,
financial position, shareholders’ equity, results of operations or prospects of the Company and its subsidiaries,
otherwise than as set forth in or contemplated by the Registration Statement, the Base Prospectus and the Prospectus
Supplement, and (iii) since such date there shall not have been any new or renewed inquiries by the Commission, FINRA or any
other regulatory body regarding the Company, the effect of which, in any such case described in clause (i), (ii) or (iii),
is, in the judgment of the Placement Agent, so material and adverse as to make it impracticable or inadvisable to proceed
with the sale or delivery of the Securities on the terms and in the manner contemplated by the Base Prospectus, Time of Sale
Prospectus and Prospectus Supplement.

 

    7

     

    

 

I.                   
The Common Stock is registered under the Exchange Act and, as of the Closing Date, the Shares shall be listed and
admitted and authorized for trading on the Trading Market or other applicable U.S. national exchange, or an application for such
listing shall have been submitted to the Trading Market, and satisfactory evidence of such action shall have been provided to the
Placement Agent. The Company shall have taken no action designed to, or likely to have the effect of terminating the registration
of the Common Stock under the Exchange Act or delisting or suspending from trading the Common Stock from the Trading Market or
other applicable U.S. national exchange, nor, except as disclosed in the Base Prospectus, Time of Sale Prospectus and Prospectus
Supplement, has the Company received any information suggesting that the Commission or the Trading Market or other U.S. applicable
national exchange is contemplating terminating such registration or listing.

  

J.                  
No action shall have been taken and no statute, rule, regulation or order shall have been enacted, adopted or issued
by any governmental agency or body which would, as of the Closing Date, prevent the issuance or sale of the Securities or materially
and adversely affect or potentially and adversely affect the business or operations of the Company; and no injunction, restraining
order or order of any other nature by any federal or state court of competent jurisdiction shall have been issued as of the Closing
Date which would prevent the issuance or sale of the Securities or materially and adversely affect or potentially and adversely
affect the business or operations of the Company.

 

K.               
The Company shall have prepared and filed with the Commission a Form 6-K with respect to the Placement, including
as an exhibit thereto this Agreement.

 

L.                
The Company shall have entered into a Purchase Agreement with each of the Purchasers and such agreements shall be
in full force and effect and shall contain representations, warranties and covenants of the Company as agreed between the Company
and the Purchasers.

 

M.              
FINRA shall have raised no objection to the fairness and reasonableness of the terms and arrangements of this Agreement.
In addition, the Company shall, if requested by the Placement Agent, make or authorize Placement Agent’s counsel to make
on the Company’s behalf, any filing with the FINRA Corporate Financing Department pursuant to FINRA Rule 5110 with respect
to the Placement and pay all filing fees required in connection therewith.

 

N.               
Prior to the Closing Date, the Company shall have furnished to the Placement Agent such further information, certificates
and documents as the Placement Agent may reasonably request.

If any of the conditions specified in
this Section 8 shall not have been fulfilled when and as required by this Agreement, or if any of the certificates, opinions,
written statements or letters furnished to the Placement Agent or to Placement Agent’s counsel pursuant to this Section
8 shall not be reasonably satisfactory in form and substance to the Placement Agent and to Placement Agent’s counsel,
all obligations of the Placement Agent hereunder may be cancelled by the Placement Agent at, or at any time prior to, the
consummation of the Closing. Notice of such cancellation shall be given to the Company in writing or orally. Any such oral
notice shall be confirmed promptly thereafter in writing.

 

SECTION
9.      WARRANT SOLICITATION
FEE. The Company hereby agrees to pay the Placement Agent a warrant solicitation fee of six percent (6%) of the gross proceeds
received by the Company for each exercise of a Warrant sold in the Placement that has been solicited by the Placement Agent at
the request of the Company. The warrant solicitation fee will be payable in cash.

 

    8

     

    

 

SECTION
10.  GOVERNING LAW; AGENT FOR SERVICE OF PROCESS,
ETC. This Agreement will be governed by, and construed in accordance with, the laws of the State of New York applicable to
agreements made and to be performed entirely in such State, without regard to the conflicts of laws principles thereof. This Agreement
may not be assigned by either party without the prior written consent of the other party. This Agreement shall be binding upon
and inure to the benefit of the parties hereto, and their respective successors and permitted assigns. Any right to trial by jury
with respect to any dispute arising under this Agreement or any transaction or conduct in connection herewith is waived. Any dispute
arising under this Agreement may be brought into the courts of the State of New York or into the federal court located in New
York, New York and, by execution and delivery of this Agreement, the Company hereby accepts for itself and in respect of its property,
generally and unconditionally, the jurisdiction of aforesaid courts. Each party hereto hereby irrevocably waives personal service
of process and consents, to the extent permitted by applicable law, to process being served in any such suit, action or proceeding
by delivering a copy thereof via overnight delivery (with evidence of delivery) to such party at the address in effect for notices
to it under this Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof.
Nothing contained herein shall be deemed to limit in any way any right to serve process in any manner permitted by law. The Company
agrees that a final judgment in any such action, proceeding or counterclaim brought in any such court shall be conclusive and
binding upon the Company and may be enforced in any other courts to the jurisdiction of which the Company is or may be subject,
by suit upon such judgment.  If either party shall commence an action or proceeding to enforce any provisions of a Transaction
Document, then the prevailing party in such action or proceeding shall be reimbursed by the other party for its attorney’s
fees and other costs and expenses incurred with the investigation, preparation and prosecution of such action or proceeding. 
In addition to and without limiting the foregoing, the Company has confirms that it has appointed Watson Farley & Williams
LLP, 250 West 55th Street, 31st Floor, New York, New York 10019, as its authorized agent (the “Authorized Agent”)
upon whom process may be served in any suit, action or proceeding arising out of or based upon the this Agreement or the Transaction
Documents or the transactions contemplated herein which may be instituted in any New York federal or state court, by the Placement
Agent, the directors, officers, partners, members, managers, employees and agents of the Placement Agent, and expressly accept
the non-exclusive jurisdiction of any such court in respect of any such suit, action or proceeding. The Company hereby represents
and warrants that the Authorized Agent has accepted such appointment and has agreed to act as said agent for service of process,
and the Company agrees to take any and all action, including the filing of any and all documents that may be necessary to continue
such appointment in full force and effect as aforesaid. The Company hereby authorizes and directs the Authorized Agent to accept
such service. Service of process upon the Authorized Agent shall be deemed, in every respect, effective service of process upon
the Company. If the Authorized Agent shall cease to act as agent for service of process, the Company shall appoint, without unreasonable
delay, another such agent in the United States, and notify you of such appointment. Notwithstanding the foregoing, any action
arising out of or based upon this Agreement may be instituted by the Placement Agent, the directors, officers, partners, members,
managers, employees and agents of the Placement Agent, in any court of competent jurisdiction in the Republic of the Marshall
Islands.  This paragraph shall survive any termination of this Agreement, in whole or in part.

 

SECTION
11.  ENTIRE AGREEMENT/MISC. This Agreement
(including the attached Indemnification Provisions) embodies the entire agreement and understanding between the parties hereto,
and supersedes all prior agreements and understandings, relating to the subject matter hereof, except for that certain Underwriting
Agreement dated June 18, 2020 by and between the Placement Agent and the Company. If any provision of this Agreement is determined
to be invalid or unenforceable in any respect, such determination will not affect such provision in any other respect or any other
provision of this Agreement, which will remain in full force and effect. This Agreement may not be amended or otherwise modified
or waived except by an instrument in writing signed by both Placement Agent and the Company. The representations, warranties,
agreements and covenants contained herein shall survive the closing of the Placement and delivery of the Securities. This Agreement
may be executed in two or more counterparts, all of which when taken together shall be considered one and the same agreement and
shall become effective when counterparts have been signed by each party and delivered to the other party, it being understood
that both parties need not sign the same counterpart. In the event that any signature is delivered by facsimile transmission or
a .pdf format file, such signature shall create a valid and binding obligation of the party executing (or on whose behalf such
signature is executed) with the same force and effect as if such facsimile or .pdf signature page were an original thereof.

 

    9

     

    

 

SECTION
12.  CONFIDENTIALITY.  The Placement
Agent (i) will keep the Confidential Information (as such term is defined below) confidential and will not (except as required
by applicable law or stock exchange requirement, regulation or legal process (“Legal Requirement”), without
the Company’s prior written consent, disclose to any person any Confidential Information, and (ii) will not use any Confidential
Information other than in connection with the Placement.  The Placement Agent further agrees, severally and not jointly,
to disclose the Confidential Information only to its Representatives (as such term is defined below) who need to know the Confidential
Information for the purpose of the Placement, and who are informed by the Placement Agent of the confidential nature of the Confidential
Information. The term “Confidential Information” shall mean, all confidential, proprietary and non-public information
(whether written, oral or electronic communications) furnished by the Company to a Placement Agent or its Representatives in connection
with such Placement Agent’s evaluation of the Placement. The term “Confidential Information” will not,
however, include information which (i) is or becomes publicly available other than as a result of a disclosure by a Placement
Agent or its Representatives in violation of this Agreement, (ii) is or becomes available to a Placement Agent or any of its Representatives
on a non-confidential basis from a third-party, (iii) is known to a Placement Agent or any of its Representatives prior to disclosure
by the Company or any of its Representatives, or (iv) is or has been independently developed by a Placement Agent and/or the Representatives
without use of any Confidential Information furnished to it by the Company. The term “Representatives” shall mean
the Placement Agent’s directors, board committees, officers, employees, financial advisors, attorneys and accountants. This
provision shall be in full force until the earlier of (a) the date that the Confidential Information ceases to be confidential
and (b) two years from the date hereof.  Notwithstanding any of the foregoing, in the event that the Placement Agent or any
of their respective Representatives are required by Legal Requirement to disclose any of the Confidential Information, such Placement
Agent and their respective Representatives will furnish only that portion of the Confidential Information which such Placement
Agent or their respective Representative, as applicable, is required to disclose by Legal Requirement as advised by counsel, and
will use reasonable efforts to obtain reliable assurance that confidential treatment will be accorded the Confidential Information
so disclosed.

 

SECTION
13.  NOTICES. Any and all notices or other
communications or deliveries required or permitted to be provided hereunder shall be in writing and shall be deemed given and
effective on the earliest of (a) the date of transmission, if such notice or communication is sent to the email address specified
on the signature pages attached hereto prior to 6:30 p.m. (New York City time) on a business day, (b) the next business day after
the date of transmission, if such notice or communication is sent to the email address on the signature pages attached hereto
on a day that is not a business day or later than 6:30 p.m. (New York City time) on any business day, (c) the third business day
following the date of mailing, if sent by U.S. internationally recognized air courier service, or (d) upon actual receipt by the
party to whom such notice is required to be given. The address for such notices and communications shall be as set forth on the
signature pages hereto.

 

SECTION
14.  PRESS ANNOUNCEMENTS. The Company agrees
that the Placement Agent shall, from and after any Closing, have the right to reference the Placement and the Placement Agent’
role in connection therewith in the Placement Agent’ marketing materials and on its website and to place advertisements
in financial and other newspapers and journals, in each case at its own expense.

 

[The remainder of this page has been
intentionally left blank.]

 

    10

     

    

 

Please confirm that the foregoing correctly
sets forth our agreement by signing and returning to Maxim the enclosed copy of this Agreement.

 

	 	Very truly yours,
	 	 
	 	MAXIM GROUP LLC
	 	 
	 	By:	/s/ Clifford A. Teller           
	 	Name: Clifford A. Teller
	 	Title:   Executive Managing Director, Investment Banking
	 	 
	 	Address for notice:
	 	405 Lexington Avenue
	 	New York, New York 10174
	 	Attention: Clifford A. Teller
	 	Email: cteller@maximgrp.com

 

Accepted and Agreed to as of

the date first written above:

 

GLOBUS MARITIME LIMITED

 

	By: 	/s/ Athanasios Feidakis	 
	Name:
    Athanasios Feidakis	 
	Title:
    Chief Executive Officer	 

 

	Address for notice:	Globus Maritime Limited
	 	128 Vouliagmenis Avenue, 3rd Floor
	 	166 74 Glyfada
	 	Athens, Greece
	 	Attention: Athanasios Feidakis, Chief Executive
    Officer
	 	Email: a.g.feidakis@globusmaritime.gr

 

[Signature page to June 2020 Placement Agency Agreement Between
Maxim

Group LLC and Globus Maritime Limited]

 

     

     

    

 

ADDENDUM A

 

INDEMNIFICATION PROVISIONS

 

In connection with the engagement of Maxim
Group LLC (the “Placement Agent”) by Globus Maritime Limited (the
 “Company”) pursuant to a placement agency agreement dated as of the date hereof, between the Company and the Placement
Agent, as it may be amended from time to time in writing (the “Agreement”), the Company hereby agrees as follows:

 

1.                 
To the extent permitted by law, the Company will indemnify the Placement Agent and its affiliates, directors, officers,
employees and controlling persons (within the meaning of Section 15 of the Securities Act of 1933, as amended, or Section 20 of
the Securities Exchange Act of 1934) against all losses, claims, damages, expenses and liabilities, as the same are incurred (including
the reasonable fees and expenses of counsel), relating to or arising out of its activities hereunder or pursuant to the Agreement,
except, with regard to the Placement Agent, to the extent that any losses, claims, damages, expenses or liabilities (or actions
in respect thereof) are found in a final judgment (not subject to appeal) by a court of law to have resulted primarily and directly
from any indemnitee’s willful misconduct or gross negligence.

 

2.                 
Promptly after receipt by the Placement Agent of notice of any claim or the commencement of any action or proceeding
with respect to which the Placement Agent is entitled to indemnity hereunder, the Placement Agent will notify the Company in writing
of such claim or of the commencement of such action or proceeding, and the Company will assume the defense of such action or proceeding
and will employ counsel reasonably satisfactory to the Placement Agent and will pay the fees and expenses of such counsel. Notwithstanding
the preceding sentence, the Placement Agent will be entitled to employ counsel separate from counsel for the Company and from any
other party in such action if counsel for the Placement Agent reasonably determines that it would be inappropriate under the applicable
rules of professional responsibility for the same counsel to represent both the Company and the Placement Agent. In such event,
the reasonable fees and disbursements of no more than one such separate counsel will be paid by the Company. The Company will have
the exclusive right to settle the claim or proceeding provided that the Company will not settle any such claim, action or proceeding
without the prior written consent of the Placement Agent, which will not be unreasonably withheld. The Placement Agent and all
other indemnitees shall not settle any claim, action or proceeding without the prior written consent of the Company.

 

3.                 
The Company agrees to notify the Placement Agent promptly of the assertion against it or any other person of any
claim or the commencement of any action or proceeding relating to a transaction contemplated by the Agreement.

 

4.                  If
for any reason the foregoing indemnity is unavailable to the Placement Agent or insufficient to hold the Placement Agent
harmless, then the Company shall contribute to the amount paid or payable by the Placement Agent, as the case may be, as a
result of such losses, claims, damages or liabilities in such proportion as is appropriate to reflect not only the relative
benefits received by the Company on the one hand, and the Placement Agent on the other, but also the relative fault of the
Company on the one hand and the Placement Agent on the other that resulted in such losses, claims, damages or liabilities, as
well as any relevant equitable considerations. The amounts paid or payable by a party in respect of losses, claims, damages
and liabilities referred to above shall be deemed to include any legal or other fees and expenses incurred in defending any
litigation, proceeding or other action or claim. Notwithstanding the provisions hereof, the Placement Agent’s share of
the liability hereunder shall not be in excess of the amount of fees actually received, or to be received, by the Placement
Agent under the Agreement (excluding any amounts received as reimbursement of expenses incurred by the Placement Agent).

 

5.                 
These Indemnification Provisions shall remain in full force and effect whether or not the transaction contemplated
by the Agreement is completed and shall survive the termination of the Agreement, and shall be in addition to any liability that
the Company might otherwise have to any indemnified party under the Agreement or otherwise.

 

    A-1

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00311-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00311-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00311-of-00352.parquet"}]]